影响在灵活尿路透镜时内分泌的因素:一个体外分析
Baiyang Song1,2, Yue Cheng3,4, Yunfei Lu5
1Department of Urology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang, 315010, People's Republic of China.
World journal of urology
|March 9, 2024
概括
在柔性尿道透镜石 (fURL) 期间优化手术内石分泌 (ICE) 涉及使用负压尿道接入 (UAS),更小的内镜直径比率和较温和的水解. 较小的石尺寸和侧面的外科位置也可以在fURL手术过程中增强ICE.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 内分泌病学 在内分泌病学.
- 医疗模拟 医疗模拟
背景情况:
- 灵活的尿道透视力托 (fURL) 是一个常见的结石去除手术.
- 术内结石分泌 (ICE) 是成功的fURL结果的关键因素.
- 优化ICE可以减少手术时间并改善患者的治疗结果.
研究的目的:
- 调查影响在灵活尿路透镜液 (fURL) 期间手术内石块排泄 (ICE) 的关键参数.
- 确定手术技术和设备选择,以提高在fURL期间的石块片段清除.
- 为改善临床实践中的ICE提供基于证据的建议.
主要方法:
- 利用3D打印的人类脏模型进行fURL的体外模拟.
- 分析了不同程度的水解,手术位置,内镜 - 皮层直径比率 (RESD),石大小和尿道接入皮层 (UAS) 类型对ICE的影响.
- 采用统计分析来确定ICE上的每个因素的意义.
主要成果:
- 所有测试的因素,包括UAS类型,RESD,水解,手术位置和石大小,都对ICE产生了重大影响 (p < 0.05).
- 负压无人机系统对ICE有显著的积极影响.
- 较小的石尺寸,较轻的水解和侧面手术位置与改善的ICE有关.
结论:
- 负压UAS,较小的RESD,较温和的水解,横向位置和较小的石尺寸对于在fURL期间增强ICE至关重要.
- 选择UAS,特别是负压变种,为ICE提供了最显著的改进.
- 这些发现可以指导泌尿科医生优化fURL程序,以便更好地清除石头.
相关概念视频
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
223
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
223
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
129
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
129
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
167
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
167
Renal Drug Excretion: Tubular Secretion
182
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
182
Renal Drug Excretion: Tubular Reabsorption
171
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
171


